SEC Form 4 · accession 0001127602-18-035013
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn Schenk
Director
Period of report
Nov 28, 2018
Accepted (ET)
Dec 3, 2018 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 28, 2018 | G | 32 | $0.00 | D | 7,877 | D | |
| Common Stock | holding | — | — | — | 3,100 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.